针对融合阳性狂宫肌肉瘤的定向治疗
George M Turco1, Sapna Oberoi2, Brian Ladle3
1Department of Pediatrics, Duke University School of Medicine, Durham, NC, USA.
Pharmacology & therapeutics
|October 2, 2025
概括
尽管经过数十年的研究,融合阳性狂肌肉瘤仍然是一个具有挑战性的儿童癌症. 针对RNA,蛋白质和免疫系统的新治疗策略为改善治疗结果提供了希望.
科学领域:
- 儿科瘤学 儿科瘤学
- 分子瘤学分子瘤学
- 癌症治疗方法 癌症治疗方法
背景情况:
- 狂肌肉瘤是最常见的儿童软组织肉瘤.
- 由PAX3::FOXO1或PAX7::FOXO1基因融合驱动的融合阳性狂宫肌肉瘤,特别难以治愈.
- 目前的标准治疗,温克里斯,阿克丁诺米辛D和环胺 (VAC) 治疗,自20世纪70年代以来一直在使用.
研究的目的:
- 审查历史背景,当前使用,临床评估和融合阳性狂宫肌肉瘤全身治疗的未来方向.
- 突出需要超越既定治疗方法的新型治疗方法.
主要方法:
- 关于融合阳性狂宫肌肉瘤治疗的历史和当代研究的文献综述.
- 分析分子驱动因素 (基因融合) 以及它们对疾病生物学的影响.
- 探索针对RNA,蛋白质和免疫系统的新兴治疗策略.
主要成果:
- 尽管在20世纪90年代发现了关键的基因融合 (PAX3::FOXO1,PAX7::FOXO1),VAC治疗仍然是治疗的标准.
- 在实现这种侵袭性儿科癌症的高治愈率方面,仍然存在重大挑战.
- 了解底层生物学对于开发更有效的治疗方法至关重要.
结论:
- 融合阳性狂宫肌肉瘤需要创新的治疗策略.
- 利用针对RNA,蛋白质和免疫系统的新方法有望促进治疗的进步.
- 对疾病生物学进行进一步的研究对于有意义的临床进展至关重要.
更多相关视频
09:21Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas
Published on: September 13, 2019
7.6K
05:08Targeted and Selective Treatment of Pluripotent Stem Cell-derived Teratomas Using External Beam Radiation in a Small-animal Model
Published on: February 17, 2019
6.6K
相关概念视频
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Combination Therapies and Personalized Medicine
5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Tumor Immunotherapy
1.8K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.8K
Abnormal Proliferation
5.1K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
